Investment opportunities in the medical device industry
Release Time:
2023-01-31
In the past decade, the US stock market has produced a total of 14 medical stocks with a market value of over 10 billion US dollars, of which 8 are medical devices, 3 are innovative drugs, and 3 are medical services. This indicates that medical device companies have high growth potential. The average research and development cycle of innovative drugs is 10 years, with a research and development cost of over $1 billion and a success rate of about 10%. In addition, innovative drugs have a patent protection period of about 10 years after their launch, and after expiration, their sales of original research drugs have significantly decreased due to the use of generic drugs; Patent Cliff;. Compared to drugs, medical devices have a shorter research and development cycle (it takes about three to five years from research and development to approval for listing), less investment, and fast returns. At the same time, due to brand and doctor usage habits, product substitutability is weak, product life cycle is longer, patent expiration does not allow competitors to quickly erode the market, and investment risk is lower. This is also the reason why the proportion of medical device companies listed on the A-share market is increasing in recent years
Next:
Related News
Careful management, attentive design, dedicated production, attentive service
Copyright ©2023 Sichuan Hang Yu Electronic Medical Equipment Manufacturing Co. Power by 300.cn
The People's Republic of China Telecommunications and Information Services Business License" No.: Shu ICP No. 16019016 "Internet Drug Information Service Qualification Certificate" No.: (Chuan)-non-operational-2018-0007 This website does not publish product information of narcotic drugs, psychotropic drugs, toxic drugs for medical use, radioactive drugs, drug rehabilitation drugs and preparations for medical institutions.
Links: 病床.cn
SAF Coolest v1.2 设置面板 AVRSS-AEXB-OASEE-SAS
无数据提示
Sorry，当前栏目暂无内容！
您可以查看其他栏目或返回 首页